04/10/2026
Dr. Rajesh Rajpal recently performed one of the first Epioxa™ procedures in the United States, bringing this next-generation, less invasive cross-linking option to patients in our region.
This milestone is especially meaningful given Dr. Rajpal’s role in the development of this technology during his time as Chief Medical Officer at Avedro, the company that pioneered corneal cross-linking and was later acquired by Glaukos.
As innovation continues to expand treatment options for patients with keratoconus, we’re honored to be at the forefront, bringing the latest advancements to the communities we serve.
Learn More: https://www.seeclearly.com/epioxa-milestone/